See the DrugPatentWatch profile for cosentyx

Cosentyx (secukinumab) is a medication used to treat several conditions, including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. While Cosentyx is generally well-tolerated, certain side effects may require dose adjustments or special considerations.

According to the Cosentyx prescribing information, there are no specific side effects that require dose adjustments [2]. However, it is important to monitor patients for any adverse reactions and adjust treatment as necessary based on the individual's clinical response and tolerance to the medication.

Patients should be advised to contact their healthcare provider if they experience any side effects, particularly those that are severe or persistent. Some side effects that may require dose adjustments or closer monitoring include:

1. Infections: Cosentyx can lower the body's ability to fight infections. Patients should be monitored for signs of infection, such as fever, sore throat, or cough. If an infection occurs, the healthcare provider may decide to temporarily stop or adjust the Cosentyx dose [2].

2. Allergic reactions: Some patients may experience allergic reactions to Cosentyx. Symptoms may include rash, itching, hives, or difficulty breathing. Severe allergic reactions require immediate medical attention and may necessitate dose adjustments or discontinuation of the medication [2].

3. Immunizations: Patients should avoid receiving live vaccines while taking Cosentyx. Healthcare providers may consider adjusting the Cosentyx dose or timing of immunizations in certain situations [2].

It is essential to follow the healthcare provider's instructions regarding dosage and administration of Cosentyx. Patients should report any side effects or concerns to their healthcare provider promptly [2].

Sources:

[1] Drugs.com. Cosentyx. <https://www.drugs.com/cosentyx.html>

[2] Novartis Pharmaceuticals Corporation. Cosentyx (secukinumab) injection, for subcutaneous use. Prescribing Information. January 2023. <https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/cosentyx.pdf>

[3] DrugPatentWatch. Cosentyx (secukinumab) Drug Profile. <https://www.drugpatentwatch.com/drugs/cosentyx>